FSTL3 and coronary atherosclerosis: Another study proved that up-regulation of FSTL3 in the serum of patients with coronary atherosclerosis could induce lipid accumulation and an inflammatory response in macrophages, thus promoting the occurrence and progression of atherosclerosis [21].